QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.

导出原文传递

翻译打印收藏纠错

作者： Eun Ju,Kim ^[1] ; Jeong Seon,Kim ^[1] ; Sieun,Lee ^[1] ; Heejin,Lee ^[2] ; Jung-Sook,Yoon ^[3] ; Ji Hyung,Hong ^[4] ; Sang Hoon,Chun ^[4] ; Der Sheng,Sun ^[4] ; Hye Sung,Won ^[4] ; Soon Auck,Hong ^[5] ; Keunsoo,Kang ^[6] ; Jeong Yeon,Jo ^[7] ; Minyoung,Choi ^[7] ; Dong Hoon,Shin ^[7] ; Young-Ho,Ahn ^[1] ; Yoon Ho,Ko ^[2]

作者单位： Department of Molecular Medicine and Tissue Injury Defense Research Center, College of Medicine, Ewha Womans University, Seoul, South Korea. ^[1] Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, South Korea. ^[2] Clinical Research Laboratory, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Gyeonggi, South Korea. ^[3] Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea. ^[4] Department of Pathology, College of Medicine, Chung-Ang University, Seoul, South Korea. ^[5] Department of Microbiology, College of Natural Sciences, Dankook University, Cheonan, Chungnam, South Korea. ^[6] Research Institute and Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi, South Korea. ^[7]

关键词 QKI epithelial-to-mesenchymal transition lung cancer miRNA-200 oral cancer